InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: None

Wednesday, 07/25/2012 1:11:32 AM

Wednesday, July 25, 2012 1:11:32 AM

Post# of 346695
This trial listed as near completion, but still recruiting: Paclitaxel and Bavituximab in Treating Patients
With HER2-Negative Metastatic Breast Cancer
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
http://www.clinicaltrials.gov/ct2/show?term=Bavituximab+OR+Peregrine&recr=Open&rank=4
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News